Dr. Vinay Prasad, the FDA’s vaccine chief, is leaving the agency by the end of April, as confirmed by the Department of Health and Human Services. His recent decisions, including the refusal to review Moderna’s application for a new mRNA flu vaccine, raised concerns in the pharmaceutical sector. Prasad will return to an academic position at the University of California San Francisco after a one-year sabbatical. This leadership change coincides with recent turnover at the CDC, which has seen the departure of its acting director.
Want More Context? 🔎
